Westlake Chemical Partners LP (WLKP) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | (m) | Share-based compensation / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 1.23B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | (m) | |
| Operating income | 355.62M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $1.23B | (m) | $355.62M | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | (m) | $1.23B | (m) | $359.54M | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | $1.17B | (m) | $319.58M | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | (m) | $1.13B | (m) | $321.84M | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | $1.10B | (m) | $339.55M | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | $1.09B | (m) | $341.95M | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | $1.14B | (m) | $390.44M | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | (m) | $1.14B | (m) | $391.24M | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | $1.19B | (m) | $367.79M | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | $1.43B | (m) | $354.65M | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $1.19B | (m) | $357.71M | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | (m) | $937.49M | (m) | $360.17M | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | $666.67M | (m) | $355.74M | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | $228.70M | (m) | $362.63M | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $250.24M | (m) | $347.69M | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | $218.78M | (m) | $393.18M | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | $214.01M | (m) | $379.50M | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | $211.61M | (m) | $414.87M | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $188.27M | (m) | $410.69M | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | $1.08B | (m) | $347.53M | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | $1.07B | (m) | $373.53M | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | $984.33M | (m) | $334.66M | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $966.67M | (m) | $352.99M | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | $993.82M | (m) | $371.13M | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | $1.01B | (m) | $363.39M | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | $1.04B | (m) | $363.82M | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | $1.09B | (m) | $350.15M | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | (m) | $1.15B | (m) | $340.85M | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | $1.27B | (m) | $342.45M | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | $1.30B | (m) | $347.88M | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | $1.29B | (m) | $349.57M | (m) | (m) | (m) | (m) | (m) |
| 2018-09-30 | (m) | $1.26B | (m) | $366.10M | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | $1.19B | (m) | $366.70M | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | $1.18B | (m) | $369.65M | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | $1.17B | (m) | $374.41M | (m) | (m) | (m) | (m) | (m) |
| 2017-09-30 | (m) | $1.16B | (m) | $370.00M | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | $1.09B | (m) | $362.41M | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | $1.01B | (m) | $352.26M | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | $986.74M | (m) | $366.44M | (m) | (m) | (m) | (m) | (m) |
| 2016-09-30 | (m) | $941.30M | (m) | $360.12M | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | $960.57M | (m) | $367.42M | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | $1.00B | (m) | $373.42M | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | $1.01B | (m) | $359.33M | (m) | (m) | (m) | (m) | (m) |
| 2015-09-30 | (m) | $1.03B | (m) | $362.58M | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | $1.18B | (m) | $430.40M | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | $1.45B | (m) | $582.25M | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | $1.75B | (m) | $716.56M | (m) | (m) | (m) | (m) | (m) |
| 2014-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Green Plains Inc. (GPRE) | United States | $1.054B | 8.70 |
| Gevo, Inc. (GEVO) | United States | $0.345B | -1.72 |
| Alto Ingredients, Inc. (ALTO) | United States | $0.289B | 8.52 |
| FutureFuel Corp. (FF) | United States | $0.225B | -6.53 |
| Comstock Inc. (LODE) | United States | $0.195B | -5.19 |
| XCF Global, Inc. (SAFX) | United States | $0.171B | -2.86 |
| CODEXIS, INC. (CDXS) | United States | $0.151B | -6.68 |
| AEMETIS, INC (AMTX) | United States | $0.128B | -1.95 |
| LanzaTech Global, Inc. (LNZA) | United States | $0.078B | 0.52 |
| REX AMERICAN RESOURCES Corp (REX) | United States | $1.437B | 10.31 |